未登录NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Schmitt, Walter; Ruehs, Hauke; Burghaus, Rolf; Diedrich, Christian; Duwal, Sulav; Eissing, Thomas; Garmann, Dirk; Meyer, Michaela; Ploeger, Bart; Lippert, Joerg
分享
收藏The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial
Joussen, Antonia M.; Wolf, Sebastian; Kaiser, Peter K.; Boyer, David; Schmelter, Thomas; Sandbrink, Rupert; Zeitz, Oliver; Deeg, Gesa; Richter, Annett; Zimmermann, Torsten; Hoechel, Joachim; Buetehorn, Ulf; Schmitt, Walter; Stemper, Brigitte; Boettger, Michael K.
分享
收藏
分享
收藏
分享
收藏How TK-TD and Population Models for Aquatic Macrophytes Could Support the Risk Assessment for Plant Protection Products
Hommen, Udo; Schmitt, Walter; Heine, Simon; Brock, Theo C. M.; Duquesne, Sabine; Manson, Phil; Meregalli, Giovanna; Ochoa-Acuna, Hugo; van Vliet, Peter; Arts, Gertie
分享
收藏
分享
收藏An Example of Population-Level Risk Assessments for Small Mammals Using Individual-Based Population Models
Schmitt, Walter; Auteri, Domenica; Bastiansen, Finn; Ebeling, Markus; Liu, Chun; Luttik, Robert; Mastitsky, Sergey; Nacci, Diane; Topping, Chris; Wang, Magnus
分享
收藏TOXICOKINETIC-TOXICODYNAMIC MODELING OF QUANTAL AND GRADED SUBLETHAL ENDPOINTS: A BRIEF DISCUSSION OF CONCEPTS
Ashauer, Roman; Agatz, Annika; Albert, Carlo; Ducrot, Virginie; Galic, Nika; Hendriks, Jan; Jager, Tjalling; Kretschmann, Andreas; O'Connor, Isabel; Rubach, Mascha Nadine; Nyman, Anna-Maija; Schmitt, Walter; Stadnicka, Julita; van den Brink, Paul J.; Preuss, Thomas G.
分享
收藏
分享
收藏
分享
收藏
分享
收藏Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: The first steps
Loizou, George; Spendiff, Martin; Barton, Hugh A.; Bessems, Jos; Bois, Frederic Y.; d'Yvoire, Michel Bouvier; Buist, Harrie; Clewell, Harvey J., III; Meek, Bette; Gundert-Remy, Ursula; Goerlitz, Gerhard; Schmitt, Walter
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏